Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 19,280 filings

Top spenders & firms Spend by issue

Clear
RR
KYLE HOUSE GROUP for US PHARMACOPEIA
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland
Foreign Relations, Health Issues
View →
Q1
BELL & LINDSAY, INC. for GOVBIZ ADVANTAGE (FOR LIFE CONNECTION OHIO)
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $60,000.00 income
Health Issues
View →
Q1
BOCKORNY GROUP, INC. for HEALTHEQUITY
1st Quarter (Jan 1 - Mar 31) 2026 · Utah · House · Senate · $80,000.00 income
Health Issues
View →
Q1
FOLEY & LARDNER LLP for ALVOGEN, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $30,000.00 income
Health Issues, Government Issues
View →
Q1
TERUMO BCT, INC. for TERUMO BCT, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Colorado · House · Senate
Trade (domestic/foreign), Health Issues
View →
Q1
DLA PIPER LLP (US) for IQVIA HOLDINGS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $60,000.00 income
Health Issues
View →
Q1
AKIN GUMP STRAUSS HAUER & FELD for MAYNE PHARMA (USA), INC.
1st Quarter (Jan 1 - Mar 31) 2026 · North Carolina · House · Senate · $70,000.00 income
Health Issues
View →
Q1
THE DUBERSTEIN GROUP INC. for MEMORIAL SLOAN KETTERING CANCER CENTER
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $45,000.00 income
Health Issues
View →
Q1
BELL & LINDSAY, INC. for DEMERX, INC
1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate · $10,000.00 income
Health Issues
View →
Q1
DLA PIPER LLP (US) for PRIMO CENTER FOR WOMEN AND CHILDREN
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $20,000.00 income
Health Issues
View →
Q1
AKIN GUMP STRAUSS HAUER & FELD for FUJIFILM HOLDINGS AMERICA CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $110,000.00 income
Health Issues
View →
Q1
BELL & LINDSAY, INC. for GOV BIZ ADVANTAGE, INC. (FOR QUANTUM KNIGHT)
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate
Computer Industry, Health Issues
View →
Q1
DLA PIPER LLP (US) for PRELUDE CORPORATION (PRELUDEDX)
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $70,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
DLA PIPER LLP (US) for CORVENT MEDICAL, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · North Dakota · $20,000.00 income
Health Issues, Defense
View →
Q1
FOLEY & LARDNER LLP for ADELANTO HEALTHCARE VENTURES, LLC
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $60,000.00 income
Health Issues
View →
Q1
BELL & LINDSAY, INC. for METABOLIC SYNDROME INSULIN INFUSION HOLDINGS LLC
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $15,000.00 income
Accounting, Health Issues
View →
Q1
GE HEALTHCARE TECHNOLOGIES INC. for GE HEALTHCARE TECHNOLOGIES INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate
Health Issues
View →
RR
DUDDINGTON GLOBAL STRATEGIES LLC for PROSPEROUS ROBOTICS
1st Quarter (Jan 1 - Mar 31) 2026 · South Dakota
Telecommunications, Health Issues
View →
Q1
AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Insurance
View →
Q1
GREENBERG TRAURIG, LLP for IMPACT HEALTH SHARING
1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate · $40,000.00 income
Health Issues, Taxation/Internal Revenue Code
View →
Q1
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for AMERICAN SOCIETY OF PEDIATRIC NEPHROLOGY
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $20,000.00 income
Budget/Appropriations, Health Issues, Medicare/Medicaid
View →
Q1
FOLEY & LARDNER LLP for ACCENTCARE, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $80,000.00 income
Health Issues
View →
Q1
AXADVOCACY GOVERNMENT RELATIONS for CHILDREN'S HEALTH DEFENSE
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income
Health Issues, Telecommunications
View →
Q1
DLA PIPER LLP (US) for COALITION FOR SMARTER REGULATION OF NICOTINE
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $120,000.00 income
Health Issues
View →
Q1
BELL & LINDSAY, INC. for OYE THEREPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · Indiana · House · Senate · $10,000.00 income
Health Issues
View →
Previous Page 84 of 772 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem